Mitesh

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches MSN/2025/038 Tier 2 – medium impact Date of issue: 19/06/2025 Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August [...]

The post Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...]

The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering [...]

The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2024/25 influenza season appeared first on Community Pharmacy England.